Teisseyre, M., Allinovi, M., Audard, V., Cremoni, M., Belvederi, G., Karamé, A., . . . Seitz-Polski, B. Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies. Elsevier.
Chicago Style (17th ed.) CitationTeisseyre, Maxime, et al. Obinutuzumab and Ofatumumab Are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies. Elsevier.
MLA (9th ed.) CitationTeisseyre, Maxime, et al. Obinutuzumab and Ofatumumab Are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies. Elsevier.
Warning: These citations may not always be 100% accurate.